狠狠色丁香久久综合婷婷亚洲成人福利在线-欧美日韩在线观看免费-国产99久久久久久免费看-国产欧美在线一区二区三区-欧美精品一区二区三区免费观看-国内精品99亚洲免费高清

            深圳遠揚化學技術有限公司
            中級會員 | 第10年

            15012456311

            英國NIBSC標準品WHO標準品應用

            時間:2017/2/7閱讀:2805
            分享:

            英國NIBSC標準品WHO標準品是深圳遠揚化學技術有限公司的熱銷產(chǎn)品,主要應用在哪些領域呢?

            英國國家生物制品檢定所是WHO的一個標準品供應中心實驗室,它的核心工作是制備、保存和分發(fā)WHO用于檢測生物制品質(zhì)量的標準品。NIBSC制備的流感毒株和檢測抗原、抗血清標準品,保障了各廠家順利的研究和生產(chǎn)。NIBSC提供對投入英國市場的生物藥品的獨立測試,尤其是用于英國兒童免疫計劃的疫苗;它同時也是歐盟控制藥品進入歐盟市場的藥品控制實驗室(OMCL)。 如果出現(xiàn)不能滿足藥品存放要求或患者出現(xiàn)不良反應等問題,NIBSC 也可對已投入歐盟市場的產(chǎn)品進行檢驗。

            NIBSC 戰(zhàn)略目標:對有關生物產(chǎn)品的問題給出回復和建議;提供生物藥品方面的國家科技力量,維持滿足科學和藥物學領域新發(fā)展需求的靈活性、專業(yè)知識和設施;

            作為化驗方法(如量化生物學活性以及確定生物產(chǎn)品特征和進行安全評估)方面的機構運營并得到認同;

            在歐洲生物產(chǎn)品的控制和標準化方面,繼續(xù)發(fā)揮科學基礎開發(fā)的中心作用;

            在生物藥品法規(guī)的科學方面幫助社會達成共識,并籍于此,與世界衛(wèi)生組織緊密合作;

            在控制和標準化的關鍵領域?qū)崿F(xiàn)和維護質(zhì)量鑒定。

            生物藥品控制

            藥品中使用的生物物質(zhì)包括病毒和細菌疫苗、從人類血液提取的產(chǎn)物、荷爾蒙以及其它諸如細胞分裂素和生長素等治療藥物。

            這些生物物質(zhì)對藥物學和公眾健康做出了巨大貢獻并發(fā)揮著越來越大的作用,它們大大改善了*的疾病預防、診斷和治療。

             

            深圳遠揚化學技術有限公司所售英國NIBSC標準品部分產(chǎn)品列表:

            (篇幅有限,更多產(chǎn)品,歡迎進入我司展臺查詢)

            07/288BCG Vaccine of Russian BCG-I sub-strain(15st WHO Reference Reagent)
            01/535Meningococcal serogroup W polysaccharide
            07/352BCG Vaccine of Russian BCG-I sub-strain(79st WHO Reference Reagent)
            07/281BCG Vaccine of Russian BCG-I sub-strain(8st WHO Reference Reagent)
            10/164Reteplase Reference Material
            95/571Interleukin-32 (Human, rDNA derived)
            13/219Influenza Antigen B/Massachusetts/02/2097 (Egg derived)
            10/149Reteplase Reference Material
            07/344BCG Vaccine of Russian BCG-I sub-strain(71st WHO Reference Reagent)
            01/484Meningococcal serogroup W polysaccharide
            13/154Influenza Antigen B/Massachusetts/02/2032 (Egg derived)
            13/151Influenza Antigen B/Massachusetts/02/2029 (Egg derived)
            10/143Reteplase Reference Material
            01/476Meningococcal serogroup W polysaccharide
            12/B623-057QCRFLUAH1N1QC1-Influenza AH1N1 QC55
            12/B623-053QCRFLUAH1N1QC1-Influenza AH1N1 QC51
            12/B623-051QCRFLUAH1N1QC1-Influenza AH1N1 QC49
            13/275Polio Anti Sabin type 58 (inactivated) Serum
            12/B623-003QCRFLUAH1N1QC1-Influenza AH1N1 QC1
            07/315BCG Vaccine of Russian BCG-I sub-strain(42st WHO Reference Reagent)
            13/285Polio Anti Sabin type 68 (inactivated) Serum
            03/104-019HTLV-4 (antibody) Monitor Sample
            13/153Influenza Antigen B/Massachusetts/02/2031 (Egg derived)
            12/B623-097QCRFLUAH1N1QC1-Influenza AH1N1 QC95
            10/144Reteplase Reference Material
            95/657Interleukin-118 (Human, rDNA derived)
            13/219Polio Anti Sabin type 2 (inactivated) Serum
            03/104-085HTLV-70 (antibody) Monitor Sample
            01/472Meningococcal serogroup W polysaccharide
            13/146Influenza Antigen B/Massachusetts/02/2024 (Egg derived)
            07/329BCG Vaccine of Russian BCG-I sub-strain(56st WHO Reference Reagent)
            13/165Influenza Antigen B/Massachusetts/02/2043 (Egg derived)
            13/281Polio Anti Sabin type 64 (inactivated) Serum
            07/306BCG Vaccine of Russian BCG-I sub-strain(33st WHO Reference Reagent)
            03/104-110HTLV-95 (antibody) Monitor Sample
            07/358BCG Vaccine of Russian BCG-I sub-strain(85st WHO Reference Reagent)
            01/452Meningococcal serogroup W polysaccharide
            13/277Polio Anti Sabin type 60 (inactivated) Serum
            07/287BCG Vaccine of Russian BCG-I sub-strain(14st WHO Reference Reagent)
            13/287Polio Anti Sabin type 70 (inactivated) Serum
            13/307Polio Anti Sabin type 90 (inactivated) Serum
            10/186Reteplase Reference Material
            10/133Reteplase Reference Material
            03/104-094HTLV-79 (antibody) Monitor Sample
            12/B623-031QCRFLUAH1N1QC1-Influenza AH1N1 QC29
            07/377BCG Vaccine of Russian BCG-I sub-strain(104st WHO Reference Reagent)
            13/269Polio Anti Sabin type 52 (inactivated) Serum
            10/179Reteplase Reference Material
            10/210Reteplase Reference Material
            13/266Polio Anti Sabin type 49 (inactivated) Serum
            07/295BCG Vaccine of Russian BCG-I sub-strain(22st WHO Reference Reagent)
            07/371BCG Vaccine of Russian BCG-I sub-strain(98st WHO Reference Reagent)
            12/B623-078QCRFLUAH1N1QC1-Influenza AH1N1 QC76
            01/462Meningococcal serogroup W polysaccharide
            95/591Interleukin-52 (Human, rDNA derived)
            01/464Meningococcal serogroup W polysaccharide
            10/159Reteplase Reference Material
            03/104-046HTLV-31 (antibody) Monitor Sample
            13/213C-Peptide, Human. 68st International Standard.
            13/222Influenza Antigen B/Massachusetts/02/2100 (Egg derived)
            07/373BCG Vaccine of Russian BCG-I sub-strain(100st WHO Reference Reagent)
            12/B623-110QCRFLUAH1N1QC1-Influenza AH1N1 QC108
            13/196C-Peptide, Human. 51st International Standard.
            12/B623-043QCRFLUAH1N1QC1-Influenza AH1N1 QC41
            01/494Meningococcal serogroup W polysaccharide
            13/192Influenza Antigen B/Massachusetts/02/2070 (Egg derived)
            07/325BCG Vaccine of Russian BCG-I sub-strain(52st WHO Reference Reagent)
            07/348BCG Vaccine of Russian BCG-I sub-strain(75st WHO Reference Reagent)
            13/223Influenza Antigen B/Massachusetts/02/2101 (Egg derived)
            12/B623-086QCRFLUAH1N1QC1-Influenza AH1N1 QC84
            13/191Influenza Antigen B/Massachusetts/02/2069 (Egg derived)
            01/488Meningococcal serogroup W polysaccharide
            07/343BCG Vaccine of Russian BCG-I sub-strain(70st WHO Reference Reagent)
            12/B623-019QCRFLUAH1N1QC1-Influenza AH1N1 QC17
            10/125Reteplase Reference Material
            10/155Reteplase Reference Material
            13/185Influenza Antigen B/Massachusetts/02/2063 (Egg derived)
            13/243C-Peptide, Human. 98st International Standard.
            13/137Influenza Antigen B/Massachusetts/02/2015 (Egg derived)
            13/201C-Peptide, Human. 56st International Standard.
            07/311BCG Vaccine of Russian BCG-I sub-strain(38st WHO Reference Reagent)
            13/242C-Peptide, Human. 97st International Standard.
            13/175C-Peptide, Human. 30st International Standard.
            13/201Influenza Antigen B/Massachusetts/02/2079 (Egg derived)
            03/104-041HTLV-26 (antibody) Monitor Sample
            03/104-074HTLV-59 (antibody) Monitor Sample
            95/646Interleukin-107 (Human, rDNA derived)
            13/156C-Peptide, Human. 11st International Standard.
            01/465Meningococcal serogroup W polysaccharide
            03/104-050HTLV-35 (antibody) Monitor Sample
            10/121Reteplase Reference Material
            13/235Influenza Antigen B/Massachusetts/02/2113 (Egg derived)
            01/519Meningococcal serogroup W polysaccharide
            07/364BCG Vaccine of Russian BCG-I sub-strain(91st WHO Reference Reagent)
            95/566Interleukin-27 (Human, rDNA derived)
            13/204C-Peptide, Human. 59st International Standard.
            13/205Influenza Antigen B/Massachusetts/02/2083 (Egg derived)
            13/241C-Peptide, Human. 96st International Standard.
            07/324BCG Vaccine of Russian BCG-I sub-strain(51st WHO Reference Reagent)
            95/626Interleukin-87 (Human, rDNA derived)

            會員登錄

            ×

            請輸入賬號

            請輸入密碼

            =

            請輸驗證碼

            收藏該商鋪

            X
            該信息已收藏!
            標簽:
            保存成功

            (空格分隔,最多3個,單個標簽最多10個字符)

            常用:

            提示

            X
            您的留言已提交成功!我們將在第一時間回復您~
            撥打電話
            在線留言